Evaluating fall prevention methods for older adults with type 2 diabetes
Evaluate the Results of Fall Prevention in Older Adults With Type 2 Diabetes Mellitus
This study is testing if a special fall prevention program can help older adults with type 2 diabetes avoid falls and improve their physical abilities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 60 Years to 60 Years |
| Sex | All |
| Sponsor | National Geriatric Hospital Government |
| Locations | 1 site (Hanoi) |
| Trial ID | NCT06345118 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to assess the effectiveness of fall prevention strategies in older adults diagnosed with type 2 diabetes mellitus. Participants will be randomly assigned to either an intervention group, which will follow the Otago Training Program for fall prevention, or a control group receiving standard diabetes care. The study will evaluate the incidence of falls and physical performance over a six-month period. By identifying risk factors and implementing targeted interventions, the trial seeks to improve safety and quality of life for elderly patients with diabetes.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 60 to 80 with type 2 diabetes and a moderate to high risk of falls.
Not a fit: Patients with acute diabetic complications or severe cognitive and mobility impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce the incidence of falls among older adults with type 2 diabetes, enhancing their safety and overall quality of life.
How similar studies have performed: Previous studies have shown success in fall prevention strategies for older adults, indicating that this approach has potential for effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For the first objective (Cross-sectional study): * Type 2 diabetic patients diagnosed using American Diabetes Association 2022 criteria * HbA1c ≥ 7.0 and ≤ 9% * Age ≥ 60 and ≤ 80 For the second objective (Longitudinal study): * All patients recruited from the first objective are at moderate or high risk of falls according to the criteria of World Guidelines for Falls Prevention and Management for Older Adults - British Geriatric Society. Exclusion Criteria: * Acute diabetic complications * Patients are in the acute phase of musculoskeletal disorders: acute gout, progressing low-grade arthritis, acute joint pain due to joint degeneration, sciatic pain, and infectious arthritis. * Patients suffer from conditions significantly affecting cognition and mobility: sequelae of stroke (with weakness, limb paralysis), muscular weakness, limb disabilities, severe heart failure, severe cognitive decline, and psychiatric disorders. * Patients have been bedridden due to illness for more than one month within the past three months up to the recruitment time. * Patients with cardiovascular diseases: chest pain, uncontrolled blood pressure ≥160/100 mmHg, untreated cardiac arrhythmia, a history of congestive heart failure, severe valvular heart disease, myocarditis or pericarditis, and hypertrophic cardiomyopathy.
Where this trial is running
Hanoi
- National Geriatric Hospital — Hanoi, Vietnam (Recruiting)
Study contacts
- Study coordinator: Hoa T Dinh, MD
- Email: dinhtrunghoa95@gmail.com
- Phone: +84858038888
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.